UTERINE FIBROIDS

Dr. Bhaskar M V, a top endovascular surgeon, leads Adhventha Center and Hospital, Bengaluru, with extensive qualifications and experience.

banner
Uterine fibroids

Uterine fibroids are noncancerous growths that develop in the uterus, also known as leiomyomas or myomas. These growths are typically composed of muscle and fibrous tissue and can vary in size, ranging from small, undetectable nodules to larger masses that can distort the shape of the uterus. Uterine fibroids are quite common, especially among women of childbearing age, and their exact cause is not fully understood. However, hormonal factors, particularly estrogen and progesterone, are believed to play a significant role in their development and growth.

The symptoms associated with uterine fibroids can vary widely depending on their size, number, and location within the uterus. Some women with fibroids may experience no symptoms at all and may only discover their presence during a routine pelvic examination. However, common symptoms include heavy menstrual bleeding (menorrhagia), prolonged menstrual periods, pelvic pain or pressure, frequent urination, difficulty emptying the bladder, and lower back or abdominal discomfort. In some cases, fibroids can also contribute to infertility or complications during pregnancy.

Treatment options for uterine fibroids depend on the severity of symptoms, the size and location of the fibroids, and the woman's age and desire for future fertility. Mild symptoms may be managed with medications to control bleeding or alleviate pain. Hormonal therapies, such as birth control pills or hormonal IUDs, can also help regulate menstrual cycles and reduce symptoms. In more severe cases or when conservative treatments are ineffective, procedures such as uterine artery embolization, myomectomy (surgical removal of fibroids), or hysterectomy (removal of the uterus) may be recommended. It's essential for women experiencing symptoms of uterine fibroids to seek medical evaluation for proper diagnosis and individualized treatment planning.

Symptoms

Symptoms of uterine fibroids include heavy menstrual bleeding, prolonged periods, pelvic pain, frequent urination, and lower back or abdominal discomfort.

Uterine fibroids can cause heavy menstrual bleeding or painful periods, known as menorrhagia or dysmenorrhea, respectively. Other symptoms may include pelvic pain or pressure, frequent urination, and discomfort during intercourse. Seeking medical evaluation can help diagnose fibroids and determine appropriate management options for symptom relief.

Uterine fibroids can lead to pelvic pressure or pain, particularly if they grow large or press against surrounding organs. This discomfort may manifest as a constant sensation of fullness or heaviness in the pelvic region. Seeking medical assessment is crucial for accurate diagnosis and symptom management.

Uterine fibroids may cause frequent urination or difficulty urinating due to their size and position. Pressure on the bladder can result in increased urination frequency, while large fibroids pressing on the urethra may lead to issues with starting or emptying the bladder. Medical evaluation is recommended for diagnosis and management.

Latest IR Technology

Latest IR technology for uterine fibroids includes minimally invasive procedures like MRI-guided focused ultrasound surgery (MRgFUS) and radiofrequency ablation.

Uterine fibroid embolization (UFE) represents the latest IR technology for fibroids. This minimally invasive procedure involves blocking the blood vessels supplying the fibroids, causing them to shrink. UFE offers advantages like shorter recovery times and preservation of the uterus, making it an appealing option for fibroid treatment.

Microwave ablation is a cutting-edge infrared (IR) technology used in treating uterine fibroids. This minimally invasive procedure involves using microwave energy to heat and destroy abnormal fibroid tissue, offering precise targeting, reduced scarring, and faster recovery compared to traditional surgery, with potential for improved patient outcomes.